Since these early experiments, other investigators have shown similar results supporting the use of MV-NIS as an imaging reporter in oncolytic viral therapy studies of ovarian cancer, pancreatic cancer, prostate cancer, and mesothelioma [88, 103, 122-124]. This evidence concerns the gene SLC5A5 and Familial prostate cancer.